| 514 / | HD | DRUG, BIO-AFFECTING AND BODY TREATING COMPOSITIONS |
|
| 1 | DF | DESIGNATED ORGANIC ACTIVE INGREDIENT CONTAINING (DOAI) {29} |
| 506 |  | .~ Ester DOAI {10} |
| 507 | DF | .~.~> R-C(=X)-N-X-C containing (e.g., hydroxamic acid ester, etc.) (R is C or H and X is chalcogen) |
| 508 | DF | .~.~> X-C=N containing (e.g., imidoester, etc.) (X is chalcogen) |
| 509 | DF | .~.~> (O=)N(=O)-O-C containing (e.g., nitrate ester, etc.) |
| 510 | DF | .~.~> Polycyclo ring system {1} |
| 512 | DF | .~.~> X-C(=X)-X containing (e.g., carbonic acid ester, thiocarbonic acid ester, etc.) (X is chalcogen) |
| 513 | DF | .~.~> C-C(=X)-X-C containing (X is chalcogen and at least one X is other than oxygen) |
| 514 | DF | .~.~> Carbon bonded to -NCX or -XCN (e.g., cyanate, thiocyanate or isothiocyanate, etc.) (X is chalcogen) {2} |
| 517 | DF | .~.~> S-X-C containing (e.g., sulfates, etc.) (X is chalcogen) {1} |
| 519 | DF | .~.~> Cyano or isocyano bonded directly to carbon {2} |
| 529 | DF | .~.~> Z-C(=O)-O-Y wherein Z is hydrogen or an organic radical bonded to the C(=O) by a carbon and Y is an organic radical bonded to the oxygen by a carbon {4} |